The clinical performance is complex and often involves multi-system congestion. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of PML requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment. The treatment and management of PML involves the individual development of treatment regimens, typically including drug therapy, rehabilitation intervention, and regular follow-up to multiple-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many of the diseases of the nervous system that have previously been difficult to treat.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of new outbreaks of PML. The platform serves a team of domestic and foreign experts in the field of neural systems related to the China International Medical Service System, providing the following services to patients: 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.